ADC Therapeutics SA

ADCTReported to SECin USCIK 0001771910Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

4
Form 4 lines at ADC Therapeutics SA, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Zaki MohamedChief Medical OfficerAwardnothing paid213,900 sharesJul 2, 2026Zaki MohamedChief Medical Officernothing paidAward · Jul 2Award213,900Jul 2, 2026
GRAHAM PETER JChief Legal OfficerAwardnothing paid221,100 sharesJul 2, 2026GRAHAM PETER JChief Legal Officernothing paidAward · Jul 2Award221,100Jul 2, 2026
Carmona JoseChief Financial OfficerAwardnothing paid203,700 sharesJul 2, 2026Carmona JoseChief Financial Officernothing paidAward · Jul 2Award203,700Jul 2, 2026
MALLIK AMEETChief Executive OfficerAwardnothing paid675,000 sharesJul 2, 2026MALLIK AMEETChief Executive Officernothing paidAward · Jul 2Award675,000Jul 2, 2026